221 related articles for article (PubMed ID: 22489133)
1. Computational identification and modeling of crosstalk between phosphorylation, O-β-glycosylation and methylation of FoxO3 and implications for cancer therapeutics.
Butt AM; Feng D; Idrees M; Tong Y; Lu J
Int J Mol Sci; 2012; 13(3):2918-2938. PubMed ID: 22489133
[TBL] [Abstract][Full Text] [Related]
2. Computational identification of interplay between phosphorylation and O-β-glycosylation of human occludin as potential mechanism to impair hepatitis C virus entry.
Butt AM; Feng D; Nasrullah I; Tahir S; Idrees M; Tong Y; Lu J
Infect Genet Evol; 2012 Aug; 12(6):1235-45. PubMed ID: 22516225
[TBL] [Abstract][Full Text] [Related]
3. Regulation of FOXO3 by phosphorylation and methylation in hepatitis C virus infection and alcohol exposure.
Tikhanovich I; Kuravi S; Campbell RV; Kharbanda KK; Artigues A; Villar MT; Weinman SA
Hepatology; 2014 Jan; 59(1):58-70. PubMed ID: 23857333
[TBL] [Abstract][Full Text] [Related]
4. Lysine methylation of FOXO3 regulates oxidative stress-induced neuronal cell death.
Xie Q; Hao Y; Tao L; Peng S; Rao C; Chen H; You H; Dong MQ; Yuan Z
EMBO Rep; 2012 Apr; 13(4):371-7. PubMed ID: 22402663
[TBL] [Abstract][Full Text] [Related]
5. Role of post translational modifications and novel crosstalk between phosphorylation and O-beta-GlcNAc modifications in human claudin-1, -3 and -4.
Butt AM; Khan IB; Hussain M; Idress M; Lu J; Tong Y
Mol Biol Rep; 2012 Feb; 39(2):1359-69. PubMed ID: 21617949
[TBL] [Abstract][Full Text] [Related]
6. Posttranslational modifications control FoxO3 activity during denervation.
Bertaggia E; Coletto L; Sandri M
Am J Physiol Cell Physiol; 2012 Feb; 302(3):C587-96. PubMed ID: 22094330
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptors: function modulation by phosphorylation and glycosylation interplay.
Kaleem A; Ahmad I; Hoessli DC; Walker-Nasir E; Saleem M; Shakoori AR; Nasir-Ud-Din
Mol Biol Rep; 2009 Apr; 36(4):631-9. PubMed ID: 18340549
[TBL] [Abstract][Full Text] [Related]
8. Methylation by Set9 modulates FoxO3 stability and transcriptional activity.
Calnan DR; Webb AE; White JL; Stowe TR; Goswami T; Shi X; Espejo A; Bedford MT; Gozani O; Gygi SP; Brunet A
Aging (Albany NY); 2012 Jul; 4(7):462-79. PubMed ID: 22820736
[TBL] [Abstract][Full Text] [Related]
9. FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics.
Jacobs FM; van der Heide LP; Wijchers PJ; Burbach JP; Hoekman MF; Smidt MP
J Biol Chem; 2003 Sep; 278(38):35959-67. PubMed ID: 12857750
[TBL] [Abstract][Full Text] [Related]
10. LKB1 downregulation may be independent of promoter methylation or FOXO3 expression in head and neck cancer.
Ekizoglu S; Dalay N; Karaman E; Akdeniz D; Ozaydin A; Buyru N
Transl Res; 2013 Aug; 162(2):122-9. PubMed ID: 23810581
[TBL] [Abstract][Full Text] [Related]
11. Wnt/β-catenin signaling protects mouse liver against oxidative stress-induced apoptosis through the inhibition of forkhead transcription factor FoxO3.
Tao GZ; Lehwald N; Jang KY; Baek J; Xu B; Omary MB; Sylvester KG
J Biol Chem; 2013 Jun; 288(24):17214-24. PubMed ID: 23620592
[TBL] [Abstract][Full Text] [Related]
12. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor.
Greer EL; Oskoui PR; Banko MR; Maniar JM; Gygi MP; Gygi SP; Brunet A
J Biol Chem; 2007 Oct; 282(41):30107-19. PubMed ID: 17711846
[TBL] [Abstract][Full Text] [Related]
13. FOXO3/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in neuroblastoma.
Geiger K; Hagenbuchner J; Rupp M; Fiegl H; Sergi C; Meister B; Kiechl-Kohlendorfer U; Müller T; Ausserlechner MJ; Obexer P
Mol Biol Cell; 2012 Jun; 23(11):2226-34. PubMed ID: 22493319
[TBL] [Abstract][Full Text] [Related]
14.
Shin H; Cha HJ; Na K; Lee MJ; Cho JY; Kim CY; Kim EK; Kang CM; Kim H; Paik YK
Cancer Res; 2018 Mar; 78(5):1214-1224. PubMed ID: 29301793
[TBL] [Abstract][Full Text] [Related]
15. mTORC2 Is the Major Second Layer Kinase Negatively Regulating FOXO3 Activity.
Jimenez L; Amenabar C; Mayoral-Varo V; Mackenzie TA; Ramos MC; Silva A; Calissi G; Grenho I; Blanco-Aparicio C; Pastor J; Megías D; Ferreira BI; Link W
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080182
[TBL] [Abstract][Full Text] [Related]
16. Prediction of human tau 3D structure, and interplay between O-β-GlcNAc and phosphorylation modifications in Alzheimer's disease: C. elegans as a suitable model to study these interactions in vivo.
Ahmad W; Shabbiri K; Ahmad I
Biochem Biophys Res Commun; 2020 Jul; 528(3):466-472. PubMed ID: 32499112
[TBL] [Abstract][Full Text] [Related]
17. Bimodal regulation of FoxO3 by AKT and 14-3-3.
Dobson M; Ramakrishnan G; Ma S; Kaplun L; Balan V; Fridman R; Tzivion G
Biochim Biophys Acta; 2011 Aug; 1813(8):1453-64. PubMed ID: 21621563
[TBL] [Abstract][Full Text] [Related]
18. Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity.
Qi W; Weber CR; Wasland K; Savkovic SD
BMC Cancer; 2011 Jun; 11():219. PubMed ID: 21639915
[TBL] [Abstract][Full Text] [Related]
19. FOXO3 is a glucocorticoid receptor target and regulates LKB1 and its own expression based on cellular AMP levels via a positive autoregulatory loop.
Lützner N; Kalbacher H; Krones-Herzig A; Rösl F
PLoS One; 2012; 7(7):e42166. PubMed ID: 22848740
[TBL] [Abstract][Full Text] [Related]
20. Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation.
Wang F; Chan CH; Chen K; Guan X; Lin HK; Tong Q
Oncogene; 2012 Mar; 31(12):1546-57. PubMed ID: 21841822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
